DENALI THERAPEUTICS INC's ticker is DNLI and the CUSIP is 24823R105. A total of 216 filers reported holding DENALI THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is 0.32 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $88,200,017 | -33.1% | 4,275,328 | -4.3% | 0.01% | -28.6% |
Q2 2023 | $131,865,169 | +24.7% | 4,468,491 | -2.7% | 0.01% | +16.7% |
Q1 2023 | $105,785,130 | -60.8% | 4,591,389 | -52.6% | 0.01% | -25.0% |
Q4 2022 | $269,523,952 | +109.5% | 9,691,620 | +131.2% | 0.01% | 0.0% |
Q3 2022 | $128,659,000 | +16.6% | 4,192,228 | +11.8% | 0.01% | +14.3% |
Q2 2022 | $110,383,000 | -10.3% | 3,750,700 | -2.0% | 0.01% | +16.7% |
Q1 2022 | $123,108,000 | -8.8% | 3,826,792 | +26.4% | 0.01% | 0.0% |
Q4 2021 | $135,030,000 | -4.3% | 3,027,571 | +8.2% | 0.01% | -14.3% |
Q3 2021 | $141,166,000 | -22.4% | 2,798,134 | +20.6% | 0.01% | -30.0% |
Q2 2021 | $182,017,000 | +58.1% | 2,320,460 | +15.1% | 0.01% | +42.9% |
Q1 2021 | $115,152,000 | -33.5% | 2,016,667 | -2.4% | 0.01% | -36.4% |
Q4 2020 | $173,138,000 | +114.2% | 2,067,073 | -8.4% | 0.01% | +83.3% |
Q3 2020 | $80,818,000 | +48.9% | 2,255,599 | +0.5% | 0.01% | +50.0% |
Q2 2020 | $54,291,000 | +83.5% | 2,245,280 | +32.9% | 0.00% | +33.3% |
Q1 2020 | $29,588,000 | +6.0% | 1,689,756 | +5.5% | 0.00% | +50.0% |
Q4 2019 | $27,910,000 | +14.4% | 1,602,182 | +0.6% | 0.00% | 0.0% |
Q3 2019 | $24,391,000 | -40.8% | 1,592,093 | -19.8% | 0.00% | -33.3% |
Q2 2019 | $41,230,000 | +6.0% | 1,986,023 | +18.6% | 0.00% | 0.0% |
Q1 2019 | $38,883,000 | +23.5% | 1,674,551 | +9.9% | 0.00% | 0.0% |
Q4 2018 | $31,477,000 | +62.5% | 1,523,584 | +70.9% | 0.00% | +200.0% |
Q3 2018 | $19,375,000 | +333.3% | 891,327 | +204.1% | 0.00% | – |
Q2 2018 | $4,471,000 | +70.9% | 293,124 | +120.6% | 0.00% | – |
Q1 2018 | $2,616,000 | – | 132,848 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Crestline Management, LP | 7,460,732 | $240,012,000 | 28.78% |
Casdin Capital, LLC | 1,500,000 | $48,255,000 | 2.16% |
Flagship Pioneering Inc. | 2,619,968 | $84,284,000 | 1.98% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 38,000 | $8,192,000 | 1.85% |
Yiheng Capital Management, L.P. | 1,014,684 | $32,642,000 | 1.49% |
SECTORAL ASSET MANAGEMENT INC | 207,100 | $6,662,000 | 1.18% |
Artal Group S.A. | 600,000 | $19,302,000 | 0.81% |
GILDER GAGNON HOWE & CO LLC | 2,619,217 | $84,260,000 | 0.78% |
Temasek Holdings (Private) Ltd | 5,369,487 | $172,736,397 | 0.73% |
BRANDYWINE MANAGERS, LLC | 9,601 | $309,000 | 0.53% |